marketcaparena
Clear
Companies ranked by total assets, in USD
CompanyTotal assetsSectorIndustryCountryExchange
1PFEPFIZER INC$201.13BHealthcarePharmaceuticalsUnited StatesNYSE
2JNJJOHNSON & JOHNSON$201.06BHealthcarePharmaceuticalsUnited StatesNYSE
3LLYELI LILLY & Co$142.28BHealthcarePharmaceuticalsUnited StatesNYSE
4ABBVAbbVie Inc.$135.12BHealthcarePharmaceuticalsUnited StatesNYSE
5MRKMerck & Co., Inc.$129.80BHealthcarePharmaceuticalsUnited StatesNYSE
6ABTABBOTT LABORATORIES$109.22BHealthcarePharmaceuticalsUnited StatesNYSE
7REGNREGENERON PHARMACEUTICALS, INC.$41.73BHealthcarePharmaceuticalsUnited StatesNasdaq
8VTRSViatris Inc$35.04BHealthcarePharmaceuticalsUnited StatesNasdaq
9VRTXVERTEX PHARMACEUTICALS INC / MA$27.42BHealthcarePharmaceuticalsUnited StatesNasdaq
10RPRXRoyalty Pharma plc$19.82BHealthcarePharmaceuticalsUnited StatesNasdaq
11ZTSZoetis Inc.$15.08BHealthcarePharmaceuticalsUnited StatesNYSE
12ELANElanco Animal Health Inc$13.56BHealthcarePharmaceuticalsUnited StatesNYSE
13OGNOrganon & Co.$13.18BHealthcarePharmaceuticalsUnited StatesNYSE
14BMRNBIOMARIN PHARMACEUTICAL INC$11.72BHealthcarePharmaceuticalsUnited StatesNasdaq
15JAZZJazz Pharmaceuticals plc$11.08BHealthcarePharmaceuticalsUnited StatesNasdaq
16ONCBeOne Medicines Ltd.$9.18BHealthcarePharmaceuticalsUnited StatesNasdaq
17PRGOPERRIGO Co plc$7.61BHealthcarePharmaceuticalsUnited StatesNYSE
18UTHRUNITED THERAPEUTICS Corp$7.22BHealthcarePharmaceuticalsUnited StatesNasdaq
19ALNYALNYLAM PHARMACEUTICALS, INC.$5.56BHealthcarePharmaceuticalsUnited StatesNasdaq
20ROIVRoivant Sciences Ltd.$5.31BHealthcarePharmaceuticalsUnited StatesNasdaq
21PBHPrestige Consumer Healthcare Inc.$4.57BHealthcarePharmaceuticalsUnited StatesNYSE
22ALKSAlkermes plc.$4.39BHealthcarePharmaceuticalsUnited StatesNasdaq
23AMRXAmneal Pharmaceuticals, Inc.$3.78BHealthcarePharmaceuticalsUnited StatesNasdaq
24PTCTPTC THERAPEUTICS, INC.$3.25BHealthcarePharmaceuticalsUnited StatesNasdaq
25IONSIONIS PHARMACEUTICALS INC$2.99BHealthcarePharmaceuticalsUnited StatesNasdaq
26LGNDLIGAND PHARMACEUTICALS INC$2.19BHealthcarePharmaceuticalsUnited StatesNasdaq
27COLLCOLLEGIUM PHARMACEUTICAL, INC$2.14BHealthcarePharmaceuticalsUnited StatesNasdaq
28ARWRARROWHEAD PHARMACEUTICALS, INC.$2.11BHealthcarePharmaceuticalsUnited StatesNasdaq
29INSMINSMED Inc$2.10BHealthcarePharmaceuticalsUnited StatesNasdaq
30CYTKCYTOKINETICS INC$1.92BHealthcarePharmaceuticalsUnited StatesNasdaq
31OPKOPKO HEALTH, INC.$1.83BHealthcarePharmaceuticalsUnited StatesNasdaq
32INVAInnoviva, Inc.$1.70BHealthcarePharmaceuticalsUnited StatesNasdaq
33TGTXTG THERAPEUTICS, INC.$1.64BHealthcarePharmaceuticalsUnited StatesNasdaq
34PAHCPHIBRO ANIMAL HEALTH CORP$1.50BHealthcarePharmaceuticalsUnited StatesNasdaq
35ANIPANI PHARMACEUTICALS INC$1.49BHealthcarePharmaceuticalsUnited StatesNasdaq
36SUPNSUPERNUS PHARMACEUTICALS, INC.$1.43BHealthcarePharmaceuticalsUnited StatesNasdaq
37GPCRStructure Therapeutics Inc.$1.43BHealthcarePharmaceuticalsUnited StatesNasdaq
38PRAXPraxis Precision Medicines, Inc.$1.39BHealthcarePharmaceuticalsUnited StatesNasdaq
39HRMYHarmony Biosciences Holdings, Inc.$1.37BHealthcarePharmaceuticalsUnited StatesNasdaq
40ABCLAbCellera Biologics Inc.$1.31BHealthcarePharmaceuticalsUnited StatesNasdaq
41XENEXenon Pharmaceuticals Inc.$1.30BHealthcarePharmaceuticalsUnited StatesNasdaq
42RAREUltragenyx Pharmaceutical Inc.$1.26BHealthcarePharmaceuticalsUnited StatesNasdaq
43MDGLMADRIGAL PHARMACEUTICALS, INC.$1.24BHealthcarePharmaceuticalsUnited StatesNasdaq
44PCRXPacira BioSciences, Inc.$1.24BHealthcarePharmaceuticalsUnited StatesNasdaq
45INDVIndivior Pharmaceuticals, Inc.$1.23BHealthcarePharmaceuticalsUnited StatesNasdaq
46BBIOBridgeBio Pharma, Inc.$1.22BHealthcarePharmaceuticalsUnited StatesNasdaq
47DNTHDianthus Therapeutics, Inc. /DE/$1.21BHealthcarePharmaceuticalsUnited StatesNasdaq
48KLRAKailera Therapeutics, Inc.$1.21BHealthcarePharmaceuticalsUnited StatesNasdaq
49PBLSParabilis Medicines, Inc.$1.18BHealthcarePharmaceuticalsUnited StatesNasdaq
50SYRESpyre Therapeutics, Inc.$1.17BHealthcarePharmaceuticalsUnited StatesNasdaq
51ORKAOruka Therapeutics, Inc.$1.14BHealthcarePharmaceuticalsUnited StatesNasdaq
52EBSEmergent BioSolutions Inc.$1.12BHealthcarePharmaceuticalsUnited StatesNYSE
53AGIOAGIOS PHARMACEUTICALS, INC.$1.11BHealthcarePharmaceuticalsUnited StatesNasdaq
54VRDNViridian Therapeutics, Inc.\DE$1.10BHealthcarePharmaceuticalsUnited StatesNasdaq
55NKTRNEKTAR THERAPEUTICS$1.10BHealthcarePharmaceuticalsUnited StatesNasdaq
56TNGXTango Therapeutics, Inc.$1.07BHealthcarePharmaceuticalsUnited StatesNasdaq
57MIRMMirum Pharmaceuticals, Inc.$1.04BHealthcarePharmaceuticalsUnited StatesNasdaq
58JANXJanux Therapeutics, Inc.$1.01BHealthcarePharmaceuticalsUnited StatesNasdaq
59DYNDyne Therapeutics, Inc.$994.01MHealthcarePharmaceuticalsUnited StatesNasdaq
60QUREuniQure N.V.$985.10MHealthcarePharmaceuticalsUnited StatesNasdaq
61ELVNEnliven Therapeutics, Inc.$910.22MHealthcarePharmaceuticalsUnited StatesNasdaq
62CRMDCorMedix Inc.$904.05MHealthcarePharmaceuticalsUnited StatesNasdaq
63KNSAKiniksa Pharmaceuticals International, plc$896.11MHealthcarePharmaceuticalsUnited StatesNasdaq
64CORTCORCEPT THERAPEUTICS INC$888.70MHealthcarePharmaceuticalsUnited StatesNasdaq
65PTGXProtagonist Therapeutics, Inc$885.54MHealthcarePharmaceuticalsUnited StatesNasdaq
66COGTCogent Biosciences, Inc.$834.55MHealthcarePharmaceuticalsUnited StatesNasdaq
67MANEVeradermics, Inc$825.74MHealthcarePharmaceuticalsUnited StatesNYSE
68TVTXTravere Therapeutics, Inc.$799.36MHealthcarePharmaceuticalsUnited StatesNasdaq
69AXSMAxsome Therapeutics, Inc.$761.45MHealthcarePharmaceuticalsUnited StatesNasdaq
70SMMTSummit Therapeutics Inc.$752.18MHealthcarePharmaceuticalsUnited StatesNasdaq
71NUVBNuvation Bio Inc.$744.50MHealthcarePharmaceuticalsUnited StatesNYSE
72IRONDisc Medicine, Inc.$735.07MHealthcarePharmaceuticalsUnited StatesNasdaq
73XNCRXencor Inc$724.96MHealthcarePharmaceuticalsUnited StatesNasdaq
74KARDKardigan, Inc.$721.79MHealthcarePharmaceuticalsUnited StatesNasdaq
75NAMSNewAmsterdam Pharma Co N.V.$704.45MHealthcarePharmaceuticalsUnited StatesNasdaq
76SNDXSyndax Pharmaceuticals Inc$703.65MHealthcarePharmaceuticalsUnited StatesNasdaq
77ZBIOZenas BioPharma, Inc.$701.69MHealthcarePharmaceuticalsUnited StatesNasdaq
78OCULOCULAR THERAPEUTIX, INC$671.32MHealthcarePharmaceuticalsUnited StatesNasdaq
79MLYSMineralys Therapeutics, Inc.$667.85MHealthcarePharmaceuticalsUnited StatesNasdaq
80MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.$603.75MHealthcarePharmaceuticalsUnited StatesNasdaq
81KURAKura Oncology, Inc.$587.79MHealthcarePharmaceuticalsUnited StatesNasdaq
82SEPNSepterna, Inc.$566.74MHealthcarePharmaceuticalsUnited StatesNasdaq
83IMNMImmunome Inc.$565.38MHealthcarePharmaceuticalsUnited StatesNasdaq
84ALMSALUMIS INC.$560.62MHealthcarePharmaceuticalsUnited StatesNasdaq
85WVEWave Life Sciences, Inc.$558.32MHealthcarePharmaceuticalsUnited StatesNasdaq
86AKTSAktis Oncology, Inc.$557.60MHealthcarePharmaceuticalsUnited StatesNasdaq
87NRIXNurix Therapeutics, Inc.$535.54MHealthcarePharmaceuticalsUnited StatesNasdaq
88ALTAltimmune, Inc.$527.21MHealthcarePharmaceuticalsUnited StatesNasdaq
89LQDALiquidia Corp$521.92MHealthcarePharmaceuticalsUnited StatesNasdaq
90GERNGERON CORP$519.01MHealthcarePharmaceuticalsUnited StatesNasdaq
91BCAXBicara Therapeutics Inc.$512.24MHealthcarePharmaceuticalsUnited StatesNasdaq
92AVTXAvalo Therapeutics, Inc.$490.78MHealthcarePharmaceuticalsUnited StatesNasdaq
93ARQTArcutis Biotherapeutics, Inc.$488.54MHealthcarePharmaceuticalsUnited StatesNasdaq
94EWTXEdgewise Therapeutics, Inc.$479.69MHealthcarePharmaceuticalsUnited StatesNasdaq
95RAPPRapport Therapeutics, Inc.$458.98MHealthcarePharmaceuticalsUnited StatesNasdaq
96SPTXSeaport Therapeutics, Inc.$441.68MHealthcarePharmaceuticalsUnited StatesNasdaq
97RYTMRHYTHM PHARMACEUTICALS, INC.$437.27MHealthcarePharmaceuticalsUnited StatesNasdaq
98MBXMBX Biosciences, Inc.$435.91MHealthcarePharmaceuticalsUnited StatesNasdaq
99ERASErasca, Inc.$435.05MHealthcarePharmaceuticalsUnited StatesNasdaq
100AVLNAvalyn Pharma Inc.$425.45MHealthcarePharmaceuticalsUnited StatesNasdaq

U.S.-exchange common stocks; ADRs and funds excluded. 342 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.